Standout Papers

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase I... 2012 2026 2016 2021 959
  1. Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen (2012)
    Eric Van Cutsem, Josep Tabernero et al. Journal of Clinical Oncology

Immediate Impact

9 from Science/Nature 86 standout
Sub-graph 1 of 20

Citing Papers

Colorectal cancer
2024 Standout
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
2023 Standout
13 intermediate papers

Works of Guy A. Van Hazel being referenced

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
2012 Standout
Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study
2010
and 3 more

Author Peers

Author Last Decade Papers Cites
Guy A. Van Hazel 1842 899 892 39 2.4k
Monica Ronzoni 1877 607 689 70 2.3k
Emmanuel Achille 2427 918 909 26 2.9k
C.-H. Köhne 1543 659 597 46 2.0k
Silvana Chiara 2450 903 896 36 2.9k
D. Méry-Mignard 2668 1063 958 26 3.1k
Catherine Julié 1647 540 611 68 2.3k
Félix Couture 2649 934 1109 45 3.2k
Graeme J. Poston 1524 1021 610 42 2.4k
Cristina Granetto 2330 971 909 64 2.8k
Giacomo Allegrini 3135 1221 1190 76 3.8k

All Works

Loading papers...

Rankless by CCL
2026